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INTRODUCTION 
T-cell lymphomas and leukemias with a mature or post-thymic immunopheno- 
type are uncommon in the United States and Europe, in contrast to Japan where 
they are frequent and where a distinctive type of adult T-cell leukemia/lymphoma 
(ATLL) is endemic in the southwestern part of the country.' Occasional sporadic 
cases of ATLL have been reported in non-endemic areas of Japan, in the United 
States, and in several other co~nt r ies .~-~  Within a two-year period, we have seen 
four patients from Michigan with ATLL at the University of Michigan. The 
neoplastic cells of three of these patients were immunophenotyped by flow 
cytometry (FCM) and FCM DNA analysis was carried out. Although the 
neoplastic cells of these patients had a helper cell (T4+) phenotype, phenotypic 
heterogeneity was detected within this population by FCM. A fourth patient, 
residing in Michigan but originating from an endemic area in Georgia, was 
extensively studied and previously reported as part of a larger series of 
With the exception of the latter patient, all patients were leukemic and two of the 
four had hypercalcemia and antibodies to the C-type retrovirus, the human T-cell 
leukemia virus (HTLV). 
MATERIALS AND METHODS 
Light Microscopic Studies 
Blood and bone marrow smears were prepared and stained with Wright's 
stain, acid phosphatase, periodic acid-Schiff (PAS), and non-specific esterase 
(alpha-naphthol butyrate) using standard techniques. Tissue was fmed in B5 or 
neutral buffered formalin and sections stained with hematoxylin and eosin 
(H&E). 
Electron Microscopic Studies 
Buffy coat preparations and tissue sections were fmed in a cacodylate-buffered 
solution containing 3% glutaraldehyde and 3% formaldehyde, processed accord- 
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ing to previously reported techniques,12 and examined and photographed in a 
Zeiss 9s electron microscope. 
Immunologic Studies 
Cell surface antigen phenotyping of Ficoll-Hypaque-separated peripheral 
blood cells or minced tissue (skin and lymph nodes) was carried out with a 
battery of monoclonal antibodies. These included: T11, T10, T9, T6, T8, T4, I2 
(HLNDR), J5 (CALLA), B1, B2, Mol, Mo2, IgG, IgM, IgA, IgD, kappa, lambda 
(Coulter Immunology), Tac (kindly provided by Dr. T.A. Waldmann), Leu 7 
(Becton-Dickinson), and TdT (immunofluorescence) (Bethesda Research Labor- 
atories). Staining was performed by an indirect immunofluorescent procedure. 
Double staining in case 3 was carried out using a single fluorochrome (FITC) and 
a cocktail of primary antibodies. To determine whether the Tac antigen was 
present exclusively on T4+ or T8+ lymphocytes, the Ficoll-Hypaque-separated 
cells were stained with the following monoclonal antibodies: T4, T8, Tac, T4 and 
Tac, T8, and Tac (TABLE 1). Sorting of T4+, T8+, T4+ Tac+, and T8+ Tac 
negative populations was carried out and the sorted populations were examined 
morphologically. DNA staining was carried out on Ficoll-Hypaque-separated 
cells using a propidium iodide (PI) solution according to Vinde10v.I~ Chicken 
erythrocytes were used as an internal DNA standard. An aliquot of the chicken 
erythrocytes was added to the suspension of leukocytes and stained with PI. DNA 
histograms were collected as a linear signal and the peak position of the chick 
cells was translocated to the same channel number. The number of cycling cells 
was calculated by integration of the S and G2M regions of the histogram and 
expressed as percent of total nuclei counted. Assays for serum antibodies against 
disrupted HTLV were performed by previously published  technique^.'^ 
Case I 
A previously healthy 44-year-old white male from Michigan initially com- 
plained of constipation, abdominal discomfort, and distention. He had lost 8-10 
pounds in the preceding three weeks. He noted generalized lymphadenopathy 
and a white blood cell count of over 100 X 109A was found. Pertinent physical 
findings included enlarged lymph nodes in the cervical and clavicular areas, a 2 
TABLE 1. Relationship of T4+, T8+, 
and Tac+ Cells (Case 3) 





T4 + Tac (cocktail) 
S U M  (T4, Tac) 
T8 + Tac (cocktail) 
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cm right axillary lymph node and bilateral inguinal nodes 1-2 cm in diameter. 
Liver and spleen were enlarged. Laboratory values were: hemoglobin 14.0 g, 
hematocrit 43, white blood count 95 X 109/1 with 98% abnormal lymphocytes with 
hyperlobulated nuclei (FIGURE IA), and a platelet count of 50 X lo9/]. Serum 
calcium was 9.1 mg/dl. Serum antibodies to disrupted HTLV viral particles were 
not detected. A bone marrow biopsy revealed foci of normal hematopoiesis, but 
large areas of the marrow were overrun by hyperlobulated lymphocytes. The 
patient was treated with vincristine, prednisone, and intrathecal methotrexate. 
The white blood cell count initially fell to 50 X 109/1 but subsequently rose to 
140 X 109/l. More aggressive therapy with vincristine, doxorubicin, and predni- 
sone resulted in a transient disease in the WBC, but the patient’s condition 
worsened, and he died 22 days after the diagnosis of his illness. At necropsy, 
widespread leukemic infiltrates were found. 
Case 2 
A 78-year-old white female was diagnosed as having chronic lymphocytic 
leukemia (CLL) at another hospital. Her white blood cell count was 98.9 X 109/1 
with 91% lymphocytes. The patient refused therapy. No skin lesions were detected. 
The spleen was palpated 10 cm below the left costal margin, and the liver was 
enlarged below the right costal margin. Two months later she was admitted to the 
University of Michigan Hospital in a cachectic state. Bilateral pulmonary 
effusions were present. Sputum grew out acid-fast bacilli, and she was treated with 
INH, Rifampin, and pyridoxine. The white blood cell count was 174 X lo9/] with 
91% lymphocytes. The hemoglobin was 12.7 mg/dl, hematocrit 34.5%, platelet 
count 124 X 109/l. The lymphocytes were small to medium-sized with multi- 
lobulated nuclei (FIGURE 1B). A bone marrow biopsy showed diffuse infiltration 
by lymphocytes with irregular nuclear contours. A morbiliform skin rash was 
biopsied and abnormal lymphoid cells were seen in the dermis as well as 
exocytosis of cells into the epidermis. The patient was treated with cytoxan, 
vincristine, and prednisone. As this therapy was not effective, she was given 
Deoxycoformycin, which was effective in reducing her white blood cell count but 
did not control her systemic disease. She continued to have pleural effusions 
containing neoplastic lymphocytes with the same phenotype as the cells in the 
peripheral blood. The patient died eight months after diagnosis. An autopsy was 
not performed. 
Case 3 
A 76-year-old male was admitted to the University of Michigan Hospital for 
“hepatitis” and “confusion.” A serum calcium was found to be 17.1 mg/dl. Positive 
findings on physical examination included several 2 X 2 cm lymph nodes in the 
right axilla, shotty left axillary lymph nodes, and bilateral inguinal lymph nodes 
about 2 X 2 cm in size. The spleen was not palpable, and the liver was 3 cm below 
the costal margin with a 10 cm span. The hemoglobin at admission was 18.4 mg/ 
dl, hematocrit 56.7%, white blood count 20.4 X 109/1, and the platelet count was 
156 X lo9/]. The differential white blood cell count contained 44% lymphocytes, 
most of which were hyperlobulated (FIGURE IC). The patient was treated with 
saline, Lasix. a single dose (350 units) of calcitonin, and 100 mg Soh-medrol. 
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FIGURE 1. Multilobulated neoplastic lymphocytes from the peripheral blood of the three 
leukemic cases. (A) Case 1. (B) Case 2, (C) Case 3. Wright’s stain X 1300. 
During the next four days, the serum calcium dropped to 10.2 mg/dl. Over the 
next week, the white blood count rose to 32.8 X 109A with 68% lymphocytes and 
then fell to 20 X 109/1 with 80% lymphocytes. Examination of spinal fluid showed 
no abnormal lymphocytes. A bone marrow aspirate and biopsy contained less 
than 10% abnormal lymphocytes. During the course of illness, the patient 
developed pleural effusions and ascites. On numerous occasions, abnormal 
lobulated lymphocytes with the same phenotype as the blood lymphocytes were 
present in fluids from both cavities. Over the next four weeks, the enlarged lymph 
nodes became smaller, and the number of abnormal lymphocytes in the blood 
decreased progressively until several days before the patient died, when abnormal 
cells were no longer detected in the blood. Occasional hyperlobulated lympho- 
cytes were still noted in the ascitic fluid several days before death. The patient 
died six weeks after onset of his illness. No evidence of lymphoma or leukemia 
was detected in autopsy tissue. Severe cytomegalovirus infection was detected in 
lungs, larynx, pancreas, adrenal glands, urethra, and kidneys. 
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Case 4 
A 30-year-old black female, who resided in Michigan but was born in Georgia, 
initially presented with skin rash and hypercalcemia of 18 mgldl. She refused an 
operation for parathyroidectomy and reappeared one month later with a serum 
calcium of 23 mg/dl. Lytic bone lesions were noted. Several skin biopsies (FIGURE 
2) revealed a large cell lymphoma (T-cell immunoblastic sarcoma). A lymph node 
biopsy showed the same type of lymphoma. The patient was treated with a variety 
of chemotherapeutic regimens with short-lived remissions and with reappearance 
of skin lesions. Further treatment was camed out at the National Institutes of 
Health. She was never leukemic during the course of her disease. The patient died 
two and one-half years after a diagnosis of lymphoma had been established. 
RESULTS 
The leukemic cells from cases 1, 2, and 3 were similar by light and electron 
microscopy as well as cytochemically. Both in blood smears and bone marrow 
aspirates, the lymphocytes were medium sized with varying degrees of nuclear 
lobulations ranging from slight to pronounced, some having a mulberry 
FIGURE 2. Lymph node biopsy from Case 4 showing a predominance of large neoplastic 
cells, some of which have markedly irregular nuclear contours. H&E X 500. 
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appearance (FIGURE 1). In  most cells, in both peripheral blood as well as in smears 
of bone marrow aspirates, the nuclear chromatin was aggregated and nucleoli 
were not evident, while in somewhat larger cells, nuclear chromatin was less 
aggregated and a single nucleolus was noted (FIGURE 1). In all cases, the 
cytoplasm of the cells was diffusely punctate acid phosphatase positive, while 
NSE and PAS stains were negative. Ultrastructurally, the neoplastic cells showed 
varying degrees of nuclear lobulation and nucleoli were inconspicuous in most 
cells but prominent in a few cells (FIGURES 3-5). The neoplastic cells in the skin 
and lymph node biopsies of case 4 consisted predominantly of large cells, some of 
which had irregular nuclear contours, while others had round to oval nuclei with 
single nucleoli (FIGURE 2). Most of the cells had ample cytoplasm. Scattered 
smaller lymphoid cells with irregular nuclei and prominent nucleoli. The 
lymphocytes in case 3 had greater nuclear irregularity than in the other three 
cases and nuclear blebs and pocket formation were more often observed (FIGURE 
5). In cases 2 and 4 small dense granules were noted in the cytoplasm of some 
cells. In all cases, the cytoplasm of the neoplastic cells contained moderate 
numbers of ribosomes, scattered mitochrondria, and rare segments of rough 
endoplasmic reticulum with collapsed cisternae. Serum antibodies to disrupted 
HTLV viral particles were detected in cases 3 and 4. Elevated levels of serum 
calcium were also noted in cases 3 and 4 (TABLE 2). 
Cell surface antigen phenotyping by FCM varied slightly from patient to 
patient (TABLE 2). In case 1, over 90% of neoplastic cells were T11+, T3+, T4+, 
FIGURE 3. Electron micrograph of leukemic cells from the peripheral blood of Case 1. 
Multilobulated nuclei are evident. X 8,300. Figure reduction 7090. 
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FIGURE 4. Electron micrograph of a leukemic lymphocyte of Case 2. The nucleus is 
multilobulated and the cytoplasm contains three dense granules and a number of 
mitochondria. X 10,OOO. 
T8+. They did not express antigens detected by monoclonal antibodies T10, T9, 
T6, Ia, J5 (CALLA), Leu 7, B1, B2, and surface immunoglobulin (SIg) light and 
heavy chains were not detected. In case 2, the neoplastic cells had the following 
phenotype: TI 1+, T3+, T4+, T8-, T10-, T9-, Ia-, JS(CALLA)-, Leu 7-, B1-, 
B2-, and SIg light and heavy chain negative (TABLE 2), whereas the cells in case 3 
had the phenotype: T11+, T10+, T3+, T4+, and Tac+ (TABLE 2). Forty percent of 
the neoplastic lymphocytes were Tac+, and all of these bore the T4 antigen, while 
none of T8+ cells were Tac+ (TABLE 1). The neoplastic cells did not express 
antigens detected by monoclonal antibodies T9, T8, T6, Ia, J5 (CALLA), Leu 7, B1, 
B2; and SIg light and heavy chains were absent. In case 4, the phenotype of the 
malignant cells in skin and lymph node was T11+, T3+, T4+, and T8-. In all 
cases, the neoplastic cells lacked TdT. DNA analysis failed to detect aneuploidy. 
In all of the cases, the number of cells in the S and G2M phase of the cell cycle 
was not increased over those of normal peripheral blood lymphocytes. 
DISCUSSION 
It is important to differentiate T-cell from B-cell lymphoproliferative disorders, 
because the former often have a more fulminant clinical course and require more 
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FIGURE 5. Electron micrograph of leukemic cells of Case 3. The nuclei are irregular and 
nuclear bleb formation is evident. X 4,300. Figure reduction 70%. 
aggressive therapy. This is especially true of cases of ATLL, which in most 
instances are associated with a median survival of less than one 
In endemic as well as non-endemic regions, the most characteristic feature of 
ATLL is the presence of pleomorphic multilobulated lymphocytes in the 
peripheral blood?-" Infiltrates of these abnormal lymphoid cells are the cause of 
lymphadenopathy, hepatosplenomegaly, skin lesions, and, less frequently, pul- 
monary  lesion^.^-^' More common in endemic areas are hypercalcemia at the 
time of diagnosis or during the course of the disease, and antibodies to 
HTLV, which are present in 90 to 100% of cases from Japan and from the 
Caribbean?~9-1'~'s-19 The mediastinum, which is frequently involved in T-cell 
lymphoblastic lymphoma, is spared in ATLL. One of three of our non-endemic 
patients had serum antibodies to HTLV, and all patients were leukemic, while the 
patient born in the endemic region was not leukemic but presented with 
hypercalcemia and skin lesions and subsequent involvement of lymph nodes. As 
in almost all reported patients with ATLL, the lymphocytes of three of four of our 
patients had a helper cell phen~type .~- '* .~~ The other patient had an anomalous 
phenotype, hitherto unreported in ATLL. The neoplastic cells had both a helper 
and suppressor cell phenotype (T11+, T3+, T4+, T8+, T6i, T10-),6 which does 
not conform to the scheme of allegedly normal intrathymic T-cell differentia- 
tion.*' In the three leukemic cases phenotyped by FCM, the neoplastic cells of 
case 3 did express the non-lineage specific T10 antigen. Thus, despite identical 
cytologic features of these T4+ leukemic cells, phenotypic heterogeneity was 
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Relatively little has been reported about HTLV seronegative cases of ATLL.5J.s 
The two cases in this series in which no HTLV antibodies were demonstrated 
were, except for the absence of hypercalcemia, clinically and morphologically 
identical to our seropositive cases as well as to seropositive cases reported 
previously. In all three cases, the leukemic cells were multilobulated both by light 
and electron microscopy and had diffuse punctate acid phosphatase positivity. 
The HTLV's positive case is highly unusual in that the patient had a spontaneous 
remission of his disease prior to death, but died with a severe CMV infection 
similar to endemic cases of ATLL, in which patients not infrequently contract 
infections by opportunistic agents? Another case of ATLL with spontaneous 
remission has been reported in Japan2* 
The neoplastic cells of case 3 were analyzed with the anti-Tac monoclonal 
antibody. This antibody, which detects the receptor for the human T-cell growth 
factor or interleukin 2 (IL2) does not bind to normal resting T lymphocytes, B 
lymphocytes, or m o n o c y t e ~ ? ~ - ~ ~  Tac monoclonal antibody does, however, identify 
HTLV-positive ATLL ~ e l l s . ~ ~ , ~ ~  It is therefore useful not only in confirming a 
diagnosis of ATLL but also in differentiating other T-cell lymphoproliferative 
disorders, such as Sezary syndrome, in which the neoplastic T-helper cells may 
cytologically mimic those seen in ATLL.26 Since it has been established that 
HTLV is T-cell tropic infecting primarily cells with a helper p h e n ~ t y p e , ~ ~ . ~ ~  the 
Tac antigen should bind only to neoplastic T4+ cells and not to T8+ cells. In the 
HTLV+ case 3, in which the neoplastic cells were tested and found to react with 
anti-Tac antibody, multiparameter analysis was employed, revealing that the 
T4+, but not the T8+, cells were Tac+. We reached this conclusion on the basis of 
staining the cells with one fluorochrome and a cocktail of primary antibodies. It 
was assumed that if the Tac antigen is present on either the T4+ or T8+ 
lymphocytes, the sum of cells positive for the individual markers would be greater 
than that of their respective cocktails (T4 or T8+Tac). If the Tac antigen is not 
present on either T4+ or T8+ cells, then the sum of the percent of cells positive 
for the individual markers should be approximately equal to their respective 
cocktails. TABLE 1 summarizes the results of this double-staining procedure. 
Additional evidence that Tac was present only on T4+ was provided by sorting of 
T4+, Tac+ and T8+, Tac- populations. The sorted T4+ Tac+ cells were the 
neoplastic hyperlobulated acid phosphatase-positive lymphocytes, while the 
T8+, Tac- population were cytologically small, normal-appearing lymphocytes 
(FIGURE 6). The hypercalcemia in this patient may be explained by the presence of 
FIGURE 6. (Left) Sorted T4+ Tac+ leukemic cell with hyperlobulated nucleus. (Right) 
Sorted T8+ Tac- small lymphocyte. Wright's stain X 1,300. 
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FIGURE 7. Bone and marrow from Case 3 showing scalloping of trabecular bone and an 
osteoclast. H&E X 200. 
increased osteoclastic activity with scalloping of trabecular bone, which was 
evident in the bone of this patient despite the absence of associated leukemic 
marrow infiltrates (FIGURE 7). This feature has been reported in endemic cases 
from the United States and is thought to be due to a lymphokine produced by the 
neoplastic cells.* 
In summary, three cases of non-endemic ATLL were analyzed by FCM. 
Cytologically, the leukemic cells were identical. In two cases, the cells had a 
helper phenotype, while in a third case both helper and suppressor cell markers 
were found in the same cells. A fourth patient, originating from an endemic area 
in Georgia, but residing in Michigan, also had a helper cell phenotype. 
Phenotypic heterogeneity among the neoplastic helper cells was detected by 
FCM. Mutliparameter analysis and cell sorting by FCM is useful in detecting 
more than one surface marker on the same cell and was essential in identifying 
the IL2 receptor on neoplastic helper cells. DNA analysis by FCM failed to detect 
an aneuploid population, and cell cycle analysis showed a low proliferative 
activity of ATLL cells. 
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